425: Strive CIO Reposts Semler Scientific Merger Update

Strive's CIO reposted a communication on X.com regarding the proposed business combination with Semler Scientific, highlighting forward-looking statements and associated risks.

Summary

• The communication was reposted on X.com by Ben Werkman, Chief Investment Officer of Strive, Inc., on December 18, 2025.
• It pertains to Strive's proposed business combination with Semler Scientific, Inc.
• The filing contains forward-looking statements regarding the outlook, strategic and financial benefits, timing of closing, and integration of the proposed transaction.
• It emphasizes that these statements involve inherent risks and uncertainties that could cause actual results to differ materially.
• Strive has filed a Registration Statement on Form S-4, which includes an Information Statement/Proxy Statement/Prospectus, with the SEC.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and related documents before making any voting or investment decisions.
• Strive, Semler Scientific, and their respective directors, executive officers, and employees may be deemed participants in the solicitation of proxies.
• The communication clarifies that it does not constitute an offer to sell or solicit securities.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily serving as a legal disclosure about a proposed merger and its associated risks, rather than a performance update or a statement of positive or negative outcomes.

Positives

• The proposed transaction is anticipated to yield strategic benefits for the combined company.
• Expected financial benefits are projected from the proposed business combination.

Negatives

• None explicitly detailed as current negative outcomes; the filing primarily outlines risks and uncertainties related to a proposed business combination.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both parties to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and changes in laws and regulations and their enforcement could impact anticipated benefits.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The outlook and expectations for the proposed transaction include anticipated strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the businesses. These are forward-looking statements subject to significant risks and uncertainties.

Management Comments

• "Although each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, there can be no assurance that the actual results... will not differ materially from any projected future results expressed or implied by such forward-looking statements."
• "Strive and Semler Scientific undertake no obligation to update or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law."

Industry Context

The announcement relates to a specific business combination, with a notable mention of risks associated with Bitcoin treasury strategies and other digital assets, indicating a strategic direction or exposure relevant to the evolving digital asset landscape within the financial or technology sectors.

Corporate Governance

Legal Proceedings

• None detailed as current; however, the risk of future legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company is noted as a potential factor affecting outcomes.

Stakeholder Impact

• Shareholders of Strive: Potential dilution due to the issuance of additional Class A common stock.
• Stockholders of Semler Scientific: Required to make a voting decision on the proposed transaction, with potential changes in share price.
• Customers of both companies: Potential for adverse reactions to the business combination.
• Employees of both companies: Potential for changes to business or employee relationships as a result of the merger.

Next Steps

• Semler Scientific stockholders are required to approve the proposed transaction.
• The proposed transaction is expected to close, subject to satisfaction of closing conditions.
• The combined businesses will undergo integration post-closing.
• Strive and Semler Scientific may file additional relevant documents with the SEC concerning the proposed transaction.

Key Dates

Keywords

Merger, Acquisition, Business Combination, Strive Inc, Semler Scientific Inc, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury Strategy